Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (131-140 of 687) with videos related to

Pageof 69
Sort By:
European Heart Journal|November 17, 2021
Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MIBertram Pitt, João Pedro Ferreira, Faiez Zannad
European Journal of Heart Failure|August 12, 2021
Target trial emulations: bridging the gap between clinical trial and real-world dataMuhammad Shariq Usman, Bertram Pitt, Javed Butler
Circulation. Heart Failure|November 25, 2024
Mineralocorticoid Receptor Antagonists in Heart Failure: An UpdateJoão Pedro Ferreira, Bertram Pitt, Faiez Zannad
The Lancet. Healthy Longevity|September 13, 2022
Histone deacetylase inhibitors for cardiovascular conditions and healthy longevityJoão Pedro Ferreira, Bertram Pitt, Faiez Zannad
Hypertension (Dallas, Tex. : 1979)|June 11, 2020
Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease: BLOCK-CKD TrialGeorge Bakris, Y Fred Yang, Bertram Pitt
JACC. Heart Failure|May 20, 2026
Enabling a Renin-Angiotensin System Inhibitor and/or a Mineralocorticoid Receptor Antagonist in Patients With Heart Failure and/or Chronic Kidney Disease: Unintended Consequences of Increased Sodium ExposureBertram Pitt, Javed Butler, Matthew R Weir
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectivesBertram Pitt, João Pedro Ferreira, Faiez Zannad
Journal of Cardiac Failure|June 10, 2006
Diuretic use, progressive heart failure, and death in patients in the DIG studyMichael Domanski, Xin Tian, Mark Haigney, et al.
Journal of Veterinary Internal Medicine|February 27, 2019
The renin-angiotensin-aldosterone system and its suppressionMarisa K Ames, Clarke E Atkins, Bertram Pitt
Future Cardiology|December 22, 2011
PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016Jerry M Buysse, I-Zu Huang, Bertram Pitt
Pageof 69

Showing results (131-140 of 687) with videos related to

Sort By:
Pageof 69
European Heart Journal|November 17, 2021
Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MIBertram Pitt, João Pedro Ferreira, Faiez Zannad
European Journal of Heart Failure|August 12, 2021
Target trial emulations: bridging the gap between clinical trial and real-world dataMuhammad Shariq Usman, Bertram Pitt, Javed Butler
Circulation. Heart Failure|November 25, 2024
Mineralocorticoid Receptor Antagonists in Heart Failure: An UpdateJoão Pedro Ferreira, Bertram Pitt, Faiez Zannad
The Lancet. Healthy Longevity|September 13, 2022
Histone deacetylase inhibitors for cardiovascular conditions and healthy longevityJoão Pedro Ferreira, Bertram Pitt, Faiez Zannad
Hypertension (Dallas, Tex. : 1979)|June 11, 2020
Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease: BLOCK-CKD TrialGeorge Bakris, Y Fred Yang, Bertram Pitt
JACC. Heart Failure|May 20, 2026
Enabling a Renin-Angiotensin System Inhibitor and/or a Mineralocorticoid Receptor Antagonist in Patients With Heart Failure and/or Chronic Kidney Disease: Unintended Consequences of Increased Sodium ExposureBertram Pitt, Javed Butler, Matthew R Weir
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectivesBertram Pitt, João Pedro Ferreira, Faiez Zannad
Journal of Cardiac Failure|June 10, 2006
Diuretic use, progressive heart failure, and death in patients in the DIG studyMichael Domanski, Xin Tian, Mark Haigney, et al.
Journal of Veterinary Internal Medicine|February 27, 2019
The renin-angiotensin-aldosterone system and its suppressionMarisa K Ames, Clarke E Atkins, Bertram Pitt
Future Cardiology|December 22, 2011
PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016Jerry M Buysse, I-Zu Huang, Bertram Pitt
Pageof 69